Oncosil Medical Limited (OSL, NeuroDiscovery Ltd) is an Australian based and ASX listed medical device company focused on localised treatments for patients with pancreatic and liver cancer. OncoSil’s lead product, OncoSil is a first in class medical device with targeted radioactive isotope (Phosphorous-32), implanted directly into a patient’s pancreatic tumors via an endoscopic ultrasound. This treatment, known as brachytherapy, is intended to deliver more concentrated and localized radiation.
Oncosil Medical Limited operators in Health Care sector and under industry of Life Sciences Tools & Services. The company website is: http://www.oncosil.com.au.
You can also check out dividend history for similar stocks in the same sector as follows:
OSL Dividend Dates
Please click the table header to sort the data.
No Dividend Dates Found